Cerberus Capital Management related stories
All articles and analysis
- Covis Pharma Buys Glaxo Portfolio
Covis Pharma -- a Switzerland-based pharmaceutical company backed by Cerberus Capital Management, Princeton Biopharma Capital Partners and Bourne Capital Partners -- is buying the U.S. commercial rights for several drugs from GlaxoSmithKline. Terms of the agreement were not disclosed. GlaxoSmithKline will retain the existing rights for the products in countries outside the United States.
- Cerberus Capital Adds Allen Ukritnukun
Cerberus Capital Management added Allen Ukritnukun as head of European Corporate Distressed Trading and Investing, the firm announced Wednesday. He will be based in London. Previously, Ukritnukun was a London-based Managing Director at Goldman Sachs within Global Credit, responsible for European private distressed trading and investing.